Next-Generation Delivery Systems for Peptides, Proteins, and Nucleic Acids
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Biologics and Biosimilars".
Deadline for manuscript submissions: 31 May 2026 | Viewed by 773
Special Issue Editor
Interests: pharmaceutical sciences; drug delivery systems; nanotechnology in pharmaceuticals; oral antibiotic formulations; controlled release; pharmacognosy; nanomaterials; biopharmaceutics
Special Issue Information
Dear Colleagues,
The rapid growth of biologics, such as peptides, proteins, and nucleic acids, has revolutionized modern therapeutics, offering highly specific and potent treatment options for a wide range of diseases. However, their clinical translation remains limited by challenges in stability, permeability and targeted delivery. This Special Issue, Next-Generation Delivery Systems for Peptides, Proteins, and Nucleic Acids, aims to highlight recent advances in innovative delivery technologies designed to overcome these barriers. It welcomes research and review articles focusing on nanocarriers, hydrogels, lipid- and polymer-based systems, micro/nano fabrication and bioinspired delivery strategies that enhance the efficacy, stability and controlled release of biomacromolecules. The Issue seeks to provide a comprehensive platform for interdisciplinary insights at the interface of pharmaceutics, materials science and molecular biology, accelerating the development of next-generation biotherapeutics.
Dr. Aun Raza
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug delivery systems
- peptide delivery
- protein therapeutics
- nucleic acid delivery
- nanocarriers
- biomaterials
- controlled release
- targeted delivery
- gene therapy
- biopharmaceutics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
